Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Benzinga’s M&A Chatter for Thursday August 14, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday August 14, 2014:

Heartland Payment Systems Acquires Leaf

The Deal:
Heartland Payment Systems (NYSE: HPY) announced Thursday, that it acquired Leaf, which created a POS tablet specifically designed for commerce. Terms of the deal were not disclosed.

Heartland Payment Systems shares closed Thursday at $47.17, a gain of $0.01%.

OmniVision Receives Non Binding Proposal for $29/Share

The Offer:
OmniVision Technologies (NASDAQ: OVTI) announced Thursday, that its board of directors has received a non-binding proposal in a letter dated August 12, 2014 from Hua Capital Management, indicating that a group of investors led by HCM proposes to acquire all of the outstanding shares of common stock of OmniVision for $29.00 per share in cash. HCM is headed by Dr. Xisheng Zhang of Hua Capital Management, whose previous company, Accelicon was acquired by Agilent in 2011.

OmniVision’s board of directors is reviewing HCM’s proposal.

OmniVision Technologies closed at $28.29 Thursday, a gain of 15%.

Report Shutterfly Receiving Competing Bids from PE Firms

Shares of Shutterfly (NASDAQ: SFLY) surged higher Thursday, on a report from The Deal that the company is receiving competing bids from private equity companies. The deal reportedly will close this year.

The Rumor:Bloomberg reported on July 2, that Shutterfly had hired Qatalyst to handle a potential sale. Deal Reporter said on July 30, that Yahoo (NASDAQ: YHOO), Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT) and Hewlett-Packard (NYSE: HPQ) were looking at Shutterfly as a potential takeover target.

Shutterfly closed Thursday at $49.67, a gain of more than 4%.

Coca-Cola Acquires 16.7% Equity Stake in Monster Beverage for $2.15B

The Deal:
The Coca-Cola Company (NYSE: KO) and Monster Beverage (NASDAQ: MNST) announced Thursday that they have entered into agreements for a long-term strategic partnership, under which Coca-Cola will acquire an approximately 16.7% stake in Monster for $2.15 billion. Coke will have two directors on Monster’s Board and will become Monster’s preferred distribution partner globally.

The deal is expected to close in late 2014 or early 2015.

Benzinga reported back in 2012, that Coca-Cola might be planning a takeover of the energy drink company.

Monster Beverage closed Thursday at $71.65, and traded as high as $97.48 after-hours on the news. Coca-Cola ended the regular session at $40.18 and traded as high as $40.82 after-hours.

Posted-In: News Rumors Management Insider Trades M&A Movers





Benzinga’s M&A Chatter for Thursday August 21, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday August 21, 2014:

Rumor of Possible Verizon Bid for Gogo

The Rumor:
Shares of in-flight Internet company, Gogo (NASDAQ: GOGO), rose early Thursday on a report from Runway Girl Network that Verizon (NYSE: VZ) could be interested in a potential partnership, joint venture or perhaps an acquisition.

Spokespersons for Verizon and Gogo declined comment on the rumor.

Gogo shares closed at $17.75 Thursday, a gain of 47%.

Dollar General Reaffirms Commitment to Buy Family Dollar

The Affirmation :D ollar General (NYSE: DG) CEO Rick Dreiling reaffirmed the company’s commitment to acquire Family Dollar (NYSE: FDO) in a statement Thursday. Dreiling said “We are disappointed that the Family Dollar Board of Directors has concluded that our proposal is not reasonably expected to lead to a superior proposal without informing itself of all relevant information. We have done extensive antitrust analysis using experienced advisers, the results of which confirm that the transaction as proposed is capable of being completed. We remain willing to share this analysis with Family Dollar and its counsel and are confident that we will be able to quickly and efficiently resolve any potential antitrust issues.”

Dreiling said the company was “carefully reviewing and considering our options. Our existing all-cash proposal coupled with manageable antitrust issues continues to make our proposal superior to the current transaction agreement with Dollar Tree (NASDAQ: DLTR).”

Dollar Tree (NASDAQ: DLTR) offered $74.50 per share in cash and stock for Family Dollar on July 28. Dollar General countered with an all-cash offer of $78.50 per share in cash on August 18.

That offer was rejected by Family Dollar’s Board.

Dollar General closed Thursday at $63.61, a loss of $0.15, while Family Dollar lost $0.40, to close at $79.41.

ScanSource Executes LOI to Acquire Imago Group

The Offer:
ScanSource (NASDAQ: SCSC) announced Thursday, the execution of a non-binding letter of intent to acquire distributor of…
continue reading





Gogo Up 6% On Rumor Verizon Mulling Bid

Courtesy of Benzinga.

Gogo (NASDAQ: GOGO) shares were sharply higher Thursday afternoon on a rumor that it could be bought out by Verizon Communications (NYSE: VZ).

Gogo, with $1.43 billion in market capitalization, offers broadband service on more than 2,000 commercial aircraft and has estimated the market opportunity for commercial aircraft is $402 million.

On Wednesday, an industry news website called Runway Girl Network said "Wall Street is now buzzing" that the far-larger Verizon might acquire Gogo or form a joint venture or partnership.

AT&T in April announced the launch of a high-speed wireless in-flight service for airlines passengers that will compete with Gogo.

AT&T's move is "doubtlessly giving food for thought" to Verizon and other major telecommunications companies, Runway Girl said.

Gogo traded recently at $17.78 a share, up 5.9 percent.

Posted-In: News Rumors Movers





Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

Courtesy of Benzinga.

Related PFE
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Pfizer Announces Submission of Palbociclib New Drug Application To The FDA
Treasury Develolping Options to Curb Inversions (Fox Business)

Pfizer (NYSE: PFE) could revive its failed effort to acquire AstraZeneca (NYSE: AZN) as early as Tuesday under British rules on mergers and acquisitions.

Pfizer is also mulling the acquisition of Actavis (NYSE: ACT), although it continues to prefer AstraZeneca, according to unnamed sources cited by Bloomberg.

AstraZeneca gained three percent and Actavis was up by nearly as much Thursday morning trading.

Pfizer is intent on obtaining a foreign headquarters in a so-called tax inversion, and wants to expand its portfolio of development drugs. Both potential targets are overseas based.

Pfizer's $116 billion bid for AstraZeneca was rebuffed in May and waiting rules in Britain require Pfizer to hold up for six months before again approaching AstraZeneca for further discussions.

But after three months, Pfizer is allowed to make an outright offer if its convinced the bid is likely to be accepted. The three-month period expires Tuesday.

Pfizer traded recently at $28.76, down 0.43 percent.

Posted-In: News Rumors M&A Intraday Update





Benzinga’s M&A Chatter for Wednesday August 20, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday August 20, 2014:

Infineon to Purchase Int’l Rectifier for $40/Share in Cash

The Deal:
Infineon Technologies (OTC: IFNNY) and International Rectifier Corporation (NYSE: IRF) announced Wednesday that they have signed an agreement under which Infineon will acquire International Rectifier for $40 per share in cash. The transaction is valued at approximately $3 billion.

The deal is expected to close in late calendar year 2014 or early calendar year 2015.

International Rectifier shares closed at $39.10 Wednesday, a gain of 47%.

NY Post Reports Iliad Speaking to Google, Microsoft About Funding T-Mobile Bid

The Rumor:
France’s Iliad (OTC: ILIAY), which offered $33 per share for a 57% stake in T-Mobile (NYSE: TMUS) on July 31, is reportedly in talks with Google (NASDAQ: GOOG) and Microsoft (NASDAQ: MSFT) regarding an increased bid, according to the NY Post. Iliad’s original bid was rejected by T-Mobile and shares of the fourth-largest U.S. carrier have fallen from the high on August 5 of $34.95 to Tuesday’s closing price of $28.95.

Spokespersons for Iliad and T-Mobile did not respond to requests for comment on the report.

T-Mobile closed Wednesday at $29.67, a gain of 2.5%.

Hellman & Friedman Made Offer for Shutterfly, Bain Capital Also Showing Interest, Could Be Valued at ~$2B, Deal Could Be Reached as Soon as Sept

The Rumor:
Share’s of Shutterfly (NASDAQ: SFLY) spiked to a high of $54.78 on Wednesday, following a report from Bloomberg that Hellman & Friedman and Bain Capital are among companies that have expressed an interest in the digital photo company. According to sources, Shutterfly could be vauled at $2 billion in a sale.

Shutterfly has been the subject of frequent takeover rumors over the past two months. Spokespersons for Shutterfly, Bain and Hellman and Friedman declined comment.

Shutterfly closed Wednesday at $50.47, a gain of more than 1%.

Posted-In: News Rumors M&A Movers





Tobacco Stocks Slump; Cause Unproven

Courtesy of Benzinga.

Related RAI
CVS Shrugs Off $2 Billion In Cigarette Sale Losses
4 Consumer Staples Stocks Trading Higher This Quarter
Is Reynolds Backing Off E-Cigs in Acquiring Lorillard? (Fox Business)

Reynolds American (NYSE: RAI) led tobacco stocks on a down tick Wednesday, dropping nearly one percent.

Reynolds' merger partner Lorillard (NYSE: LO) was also down by 0.6 percent and Altria Group (NYSE: MO) slumped more than 0.5 percent. Other cigarette makers were dropping with no news to account for the movement.

The relatively obscure Indian publication Deccan Chronicle of Hyderabad, India, said Wednesday that Indian health officials are set to ban e-cigarettes, but the item is vaguely worded and ill-sourced, and has been ignored by major news organizations.

E-cigarettes today account for $1 billion of the tobacco industry's $35 billion in annual sales, but Wells Fargo says the devices could hit $10 billion by 2018.

Wales has proposed banning the devices later this year, and the World Health Organization caused a stir last spring with a leaked memo that appeared to call for restrictions.

Posted-In: News Rumors Intraday Update





3 Companies That Should Grab Xbox Entertainment Studios

Courtesy of Benzinga.

Related TWX
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Lionsgate Could Be Losing Billions To 'Hunger Games' Pirates
Hectic Week in Tech as Major M&A Breaks Down (Fox Business)

Time Warner (NYSE: TWX) is rumored to be interested in acquiring Xbox Entertainment Studios from Microsoft (NASDAQ: MSFT).

Few analysts were interested in talking to Benzinga about the rumor, which may turn out to be completely false given Microsoft's official statement on the matter.

Global Equities Research analyst Trip Chowdhry told Benzinga that he thinks it would be smart for Microsoft to sell the studio.

"Under the new CEO, Microsoft is focusing on the core businesses," said Chowdhry. "Anything else, they're probably going to divest in it. Who else may be interested in the studio? I don't know."

Albert Fried & Company analyst Rich Tullo told Benzinga that he thinks it is more likely that Microsoft will simply close the division and take the write-off.

Whatever happens, there are a few firms that may be interested in a buyout. Read on to see which ones could pick up the studio.

Related Link: Xbox, PlayStation TV Ad Spend Could Reach $125 Million In 2014

1. Lionsgate (NYSE: LGF)

Lionsgate struck gold when it acquired the rights to The Hunger Games. The first two films grossed more than $400 million in the United States alone.

Lionsgate had hoped that Divergent would prove to be another cash cow, but the first film ended its run at just $150 million. With an $85 million budget, the movie was profitable, but it is nowhere near the size of the Hunger Games franchise.

If Lionsgate wants another smash hit, the studio might want to examine Xbox Entertainment Studios. At the very least, this studio would give Lionsgate the chance to produce a movie based on the …
continue reading





NY Post Reports Iliad Speaking to Google, Microsoft About Funding T-Mobile Bid

Courtesy of Benzinga.

France’s Iliad (OTC: ILIAY), which offered $33 per share for a 57% stake in T-Mobile (NYSE: TMUS) on July 31, is reportedly in talks with Google (NASDAQ: GOOG) and Microsoft (NASDAQ: MSFT) regarding an increased bid, according to the NY Post. Iliad’s original bid was rejected by T-Mobile and shares of the fourth-largest U.S. carrier have fallen from the high on August 5 of $34.95 to Tuesday’s closing price of $28.95.

View full article http://nypost.com/2014/08/19/iliad-looks-to-google-microsoft-for-help-wi…

Posted-In: News Rumors Management M&A Movers





Benzinga’s M&A Chatter for Tuesday August 19, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday August 19, 2014:

GigOptix Proposes to Acquire GSI Technology for $6.50/Share in Cash, Stock Deal

The Offer:
GigOptix (NYSE MKT: GIG) announced Tuesday that it is proposing to acquire all of the outstanding shares of GSI Technology (NASDAQ: GSIT) for $6.50 per share, consisting of $2.00 per share in cash, plus GigOptix common stock worth $1.33 based upon the volume-weighted average price of GigOptix’s common stock for the three trading days ending one day prior to the closing of the combination and a special dividend of $3.17 per share in cash payable by GSI Technology.

GSI Technology acknowledged the unsolicited, non-binding and conditional proposal from GigOptix, and said its Board of Directors will promptly and carefully review and consider the proposal, respond to it and advise its stockholders of the Board’s response.

GSI Technology closed at $5.41 Tuesday, a gain of 9.55%. GigOptix shares rose $0.01, to close at $1.34.

Allergan Could Acquire Salix for as Much as $190/Share

The Rumor:Shares of Salix Pharmaceuticals (NASDAQ: SLXP) rose sharply Tuesday, on a report from WSJ that Allergan (NYSE: AGN) could acquire the Raleigh, NC drug company for as much as $190 per share or $10 billion, according to sources. The rumored move is being seen as an attempt to make it more difficult for Valeant Pharmaceuticals (NYSE: VRX) to acquire Allergan.

Shares of Jazz Pharmaceuticals rose almost 3% for the day, on reports it too could be a potential takeover target.

Allergan declined comment on the rumor. Salix did not respond to a request for a comment.

Salix Pharmaceuticals closed Tuesday at $160.80, a gain of 15.5%, while Allergan closed at $161.82, a gain of 4%. Shares of Valeant closed at $113.72 a gain of 3.5%.

Report Family Dollar Likely to Reject Dollar General Bid

The Rumor:
CNBC’s David Faber reported Tuesday that Family Dollar’s (NYSE: FDO) Board of Directors is likely to meet this week to discuss the bid…
continue reading





PetSmart Up On Report It Will Go On Block

Courtesy of Benzinga.

Related PETM
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Markets Edge Lower; American Eagle Profit Beats Street View
Facing Activist Pressure, PetSmart Reviews Capital Structure (Fox Business)

PetSmart (NASDAQ: PETM) shares spiked Tuesday on a report that the company will explore a potential sale.

Reuters said several shareholders led by activist investor Jana Partners have succeeded in efforts pushing the pet supply retailer to sell itself.

PetSmart may announce plans to explore strategic alternatives as soon as this week, according to an unnamed source cited by Reuters.

Jana, led by activist investor Barry Rosenstein, has held an 9.8 percent stake in PetSmart since last month when it called on Petsmart to review strategic alternatives, including a sale.

It sent a similar letter to PetSmart last week and on Monday disclosed it had received an anonymously delivered internal PetSmart document that outlined how it planned to fend off Jana.

PetSmart closed at $69.70, up 1.84 percent.

Posted-In: News Rumors M&A Hot After-Hours Center





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Chart School

What the Baby Boomers turned Retirement Boomers mean for Growth, Jobs, Inflation and the Markets

Courtesy of Doug Short.

Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives.

More than a year ago, in spring of 2013, I wrote 2 posts about how the retirement wave of the Baby Boomer generation would result in much lower growth, but full employment (see US Economy: Below Stall Speed or Already Above Potential? and Forget the Jobless Recovery, Get Ready for the Full-Employed Recession). Though more and more economists now recognize that it is to a large extend this retirement wave that has led to a huge exit out of the labor force, measured by the falling labor ...



more from Chart School

Insider Scoop

UPDATE: Symmetry Medical to Sell OEM Solutions Business to Tecomet, Spinoff Surgical Unit

Courtesy of Benzinga.

Related SMA Symmetry Medical To Sell Business That Makes Up 80% Of Revenue US Stock Futures Signal Higher Start On Wall Street Mid-Market Report: Dealmaking on the Rise (Fox Business)

Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, today announced that it has signed a definitive agreement with Symmetry Medical Inc. (N...



http://www.insidercow.com/ more from Insider

Zero Hedge

When 'Anti-Government' Violence Erupts, Who Is Really At Fault?

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Submitted by Brandon Smith of Alt-Market blog,

This past week, I have been examining a recently leaked document from the Department Of Homeland Security entitled “Domestic Violent Extremists Pose A Threat To Government Officials And Law Enforcement.” (Yes; the title leaves nothing to the imagination.)

Generally, such documents are not classified. But it is internally accepted within establishment agencies that they should not be shared with the public....



more from Tyler

Phil's Favorites

Argentine peso hits record lows on increased uncertainty

Argentine peso hits record lows on increased uncertainty

Courtesy of SoberLook.com

Argentina is showing signs of stress, as the official exchange rate has the US dollar now quoted 8.4 pesos - a new record.

Chart shows USD appreciating against ARS (source: Investing.com)


The "parallel" exchange rate also hit a record, with the dollar quoted at 14 pesos - a 67% premium to the official rate. Note that before the first devaluation in 2002 (see this ...



more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Option Review

CME Group Put Options Active

Options volume on the provider of futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals and alternative investment products is well above average on Thursday morning, due in large part to a sizable put spread initiated in the 19Sep’14 expiry contracts. Shares in CME Group (Ticker: CME) are up slightly on the day, trading 0.25% higher at $74.34 as of the time of this writing.

The largest trade on CME today appears to be a bear put spread in which roughly 1,500 of the 19Sep’14 74.0 strike puts were purchased at a premium of $1.44 each against the sale of the same number of t...



more from Caitlin

Sabrient

Sector Detector: Bullish investors jockey for position as if the correction is over

Courtesy of Sabrient Systems and Gradient Analytics

As many investors enjoy the final weeks of summer, some optimistic bulls seem to be positioning themselves well ahead of Labor Day in anticipation of a fall rally. Indeed, last week’s action was impressive. After only a mere 4% correction, investors continued to brush off the disturbing violence both at home and abroad, and they took the minor pullback as their next buying opportunity. But was that really all the pullback we’re going to get this year? I doubt it. But I also believe that nothing short of a major Black Swan event can send this market into a deep correction.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then ...



more from Sabrient

OpTrader

Swing trading portfolio - week of August 18th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

The Stock World Weekly Newsletter is ready to go! View it here: Stock World Weekly. Just put in your user name and password, or take a free trial. 

 

#120692880 / gettyimages.com ...

more from SWW

Market Shadows

Helen Davis Chaitman Reviews In Bed with Wall Street.

Author Helen Davis Chaitman is a nationally recognized litigator with a diverse trial practice in the areas of lender liability, bankruptcy, bank fraud, RICO, professional malpractice, trusts and estates, and white collar defense. In 1995, Ms. Chaitman was named one of the nation's top ten litigators by the National Law Journal for a jury verdict she obtained in an accountants' malpractice case. Ms. Chaitman is the author of The Law of Lender Liability (Warren, Gorham & Lamont 1990)... Since early 2009, Ms. Chaitman has been an outspoken advocate for investors in Bernard L. Madoff Investment Securities LLC (more here).

Helen Davis Chaitman Reviews In Bed with Wall Street. 

By Helen Davis Chaitman   

I confess: Larry D...



more from Paul

Digital Currencies

BitLicense Part 1 - Can Poorly Thought Out Regulation Drive the US Economy Back into the Dark Ages?

Courtesy of Reggie Middleton.

An Op-Ed piece penned by Veritaseum Chief Contracts Officer, Matt Bogosian

This past weekend (despite American Airlines' best efforts), Reggie and I made it to the Second Annual North American Bitcoin Conference in Chicago. While there were some very creative (and very ambitious) ideas on how to try to realize the disruptive Bitcoin protocol, one of the predominant topics of discussion was New York Superintendent of Financial Services Benjamin Lawsky's proposed Bitcoin regulations (the BitLicense proposal) - percieved by many participants at the event as an apparent ...



more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>